Production (Stage)
Tectonic Therapeutic, Inc.
TECX
$21.65
-$0.55-2.48%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -15.91M | -12.37M | -17.72M | -12.67M | -15.22M |
Total Depreciation and Amortization | 360.00K | 508.00K | 424.00K | 336.00K | 377.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 2.61M | 648.00K | 1.96M | 2.24M | 2.69M |
Change in Net Operating Assets | -151.00K | -5.60M | -4.27M | -3.29M | 2.88M |
Cash from Operations | -13.08M | -16.82M | -19.60M | -13.38M | -9.27M |
Capital Expenditure | -27.00K | -3.00K | -153.00K | 4.00K | -4.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -27.00K | -3.00K | -153.00K | 4.00K | -4.00K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -118.00K | -115.00K | -120.00K | -122.00K | -118.00K |
Issuance of Common Stock | 178.24M | -- | 77.00K | 97.24M | 4.00K |
Repurchase of Common Stock | -- | -1.10M | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | 147.00K | -6.24M | 82.62M | -554.00K |
Cash from Financing | 178.12M | -1.07M | -6.29M | 179.74M | -668.00K |
Foreign Exchange rate Adjustments | -5.00K | 37.00K | 15.00K | 16.00K | -76.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 165.01M | -17.86M | -26.03M | 166.38M | -10.02M |